Back
- 01
- MD Anderson and Kymab announce research and development strategic partnership in immuno-oncology
- Lymphoma/Myeloma symposium for patients and caregivers set for Feb. 6
- Study reveals potential therapy targets for triple-negative breast cancer
- MD Anderson and Enumeral enter into collaborative research and development agreement
- MD Anderson Applauds State of the Union Call to Cure Cancer
- New findings may enhance PARP inhibitors therapy in breast cancer
- MD Anderson, AbbVie connect to advance cancer immunotherapy
- Potential therapeutic targets identified for multiple sclerosis
- Targeted Axillary Dissection of lymph nodes after chemotherapy improves staging accuracy of node-positive breast cancer patients
- MD Anderson joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention
- Multi-center study reveals unique subtypes of most common malignant brain cancer
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.